The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a breakthrough after 70 years of incremental innovation that appears to avoid side effects ...

Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.

About a third of people with schizophrenia are resistant to conventional antipsychotic treatment. The current "pharmaceutical arsenal is limited". Clinical trials for new medications are expensive ...

While antipsychotics can be effective for some patients, they come with well-known side effects, including an increased risk ...

A new study by researchers at the University of Waterloo demonstrates that antipsychotic medications significantly worsened behavior in nursing home residents. “The proportion of long-term care ...

Researchers from the National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, Technology ...

The FDA approval of Alkermes' new antipsychotic drug Lybalvi couldn't have gone any better for the company, but it could still face a big challenge positioning the new drug in the highly ...

A disproportionately high number of people admitted to long-term care facilities during the COVID-19 pandemic's first year were on antipsychotic medications, recently published Brock-led research ...

A new study conducted by researchers at the University ... It found that residents who were given antipsychotic medications showed a significant worsening of their behaviors.

All these changes have to be taken into account, and they explain why, for example, elderly persons are more sensitive to benzodiazepine or antipsychotic effects, experiencing stronger sedation ...

In a guideline published online Dec. 9 in Schizophrenia Bulletin, recommendations are presented for the use of metformin to prevent antipsychotic-induced weight gain (AIWG). A disproportionately ...

Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...